Skip to main content
    I

    Intelligent Bio Solutions Inc. (INBS)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NASDAQ

    $1.52
    -0.24 (-13.64%)

    Market Cap: $5.84M

    Last updated: Nov 17, 2026 at 11:03 AM ET

    Intelligent Bio Solutions Inc. (INBS) Valuation Multiples

    Updated Nov 17, 2026. Multiples are computed from end-of-day prices, company filings and consensus analyst estimates.

    Intelligent Bio Solutions (INBS) trades at 1.0x sales and 0.6x book value. Its P/B of 0.6x is below its 5-year median of 0.7x.

    Current Multiples

    MultipleValue
    P/E (trailing)N/A
    Forward P/EN/A
    Price to sales1.0x
    Price to book0.6x
    EV/FCF0.1x
    PEGN/A
    FCF yield-253.2%
    As of Nov 17, 2026

    Historical Medians

    MultipleCurrent5-year median10-year median
    P/B0.6x0.7xN/A
    Medians of month-end values through Oct 2026: 51 months (5-year).

    Valuation History

    Over the 5 of the 6 year ends shown that have a P/B, its P/B ranged from 0.4x in 2022 to 8.7x in 2024.

    Year endPriceP/SP/B
    2025$9.53N/A0.8x
    2024$14.000.7x8.7x
    2023$40.560.3x1.2x
    2022$479.95N/A0.4x
    2021$3,445.38N/A2.1x
    2020$17,767.11N/AN/A
    Each year's multiples use the split-adjusted closing price of that year's last trading day over trailing per-share results as reported.

    GNG Valuation

    GNG viewUndervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About INBS

    Is INBS stock overvalued?

    GNG's valuation label for INBS is Undervalued.

    What is INBS's price to sales ratio?

    Intelligent Bio Solutions has a price to sales ratio of 1.0x.